Welcome to our dedicated page for ACM Research SEC filings (Ticker: ACMR), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Our SEC filing database is enhanced with expert analysis from Rhea-AI, providing insights into the potential impact of each filing on ACM Research's stock performance. Each filing includes a concise AI-generated summary, sentiment and impact scores, and end-of-day stock performance data showing the actual market reaction. Navigate easily through different filing types including 10-K annual reports, 10-Q quarterly reports, 8-K current reports, proxy statements (DEF 14A), and Form 4 insider trading disclosures.
Designed for fundamental investors and regulatory compliance professionals, our page simplifies access to critical SEC filings. By combining real-time EDGAR feed updates, Rhea-AI's analytical insights, and historical stock performance data, we provide comprehensive visibility into ACM Research's regulatory disclosures and financial reporting.
ACM Research (ACMR) filed a Form 4 reporting that subsidiary CFO Lisa Feng exercised 15,000 stock options at $5.60 and immediately sold the same number of Class A shares at $26.00 on 06/24/2025 under a Rule 10b5-1 plan. Cash proceeds totaled roughly $390 k; her beneficial ownership remains 50,001 shares, indicating no net change in holdings.
ACM Research has filed a Form 144 notice indicating a proposed sale of 15,000 shares of common stock through broker Morgan Stanley Smith Barney LLC. The shares have an aggregate market value of $390,000, with the sale planned for June 24, 2025, on the NASDAQ exchange.
Key transaction details:
- Shares were acquired through a stock option exercise from the issuer on June 24, 2025
- Payment was made in cash on the same date
- Total shares outstanding: 63,864,504
- No other securities were sold by the seller in the past 3 months
Form 144 is required for proposed sales of restricted securities and must be filed by affiliates of the issuer. The seller has certified no knowledge of undisclosed material adverse information regarding the company's operations.